This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Thrombospondin

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 7: Line 7:
== Relevance ==
== Relevance ==
TSP-1 and TSP-2 are potent inhibitors of angiogenesis and thus are studied in cancer treatments<ref>PMID:22553494</ref>.
TSP-1 and TSP-2 are potent inhibitors of angiogenesis and thus are studied in cancer treatments<ref>PMID:22553494</ref>.
 +
 +
== Disease ==
 +
TSP-2 mutation is associated with coronary artery disease<ref>PMID:18499674</ref>.
 +
== Structural highlights ==
== Structural highlights ==

Revision as of 11:55, 20 December 2016

Caption for this structure

Drag the structure with the mouse to rotate

3D structures of thrombospondin

Updated on 20-December-2016

References

  1. Adams JC. Thrombospondin-1. Int J Biochem Cell Biol. 1997 Jun;29(6):861-5. PMID:9304800
  2. Lawler PR, Lawler J. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. Cold Spring Harb Perspect Med. 2012 May;2(5):a006627. doi:, 10.1101/cshperspect.a006627. PMID:22553494 doi:http://dx.doi.org/10.1101/cshperspect.a006627
  3. Carlson CB, Liu Y, Keck JL, Mosher DF. Influences of the N700S thrombospondin-1 polymorphism on protein structure and stability. J Biol Chem. 2008 Jul 18;283(29):20069-76. Epub 2008 May 22. PMID:18499674 doi:10.1074/jbc.M800223200

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Michal Harel, Joel L. Sussman

Personal tools